Brind.

Dexcom received its first FDA approval in 2006.

5 reports, 1 independent Updated Aug 1

Gone quiet

Reports: 5
Developments: 1
Repetition: 80%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Dexcom received its first FDA approval in 2006.

Who's involved

What this event is mainly about

FDA Dexcom

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
- Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
- Oura announces partnerships with Dexcom and Resmed for health feature integration, while noting that regulatory uncertainty affects its product scope.Wed 08:52

Coverage

Newest first; wire copies grouped

Aug 14StockStory3 Reasons We’re Fans of DexCom (DXCM) Over the last six months, DexCom’s shares have sunk to $80.25, producing a disappointing 9.9% loss - a stark contrast to the S&P 500’s 5.8% gain. This may have i
Jul 31StockStoryDexCom’s (NASDAQ:DXCM) Q2 Sales Beat Estimates Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.2% year on year to $1.16 billion. The

3 more outlets ran the same wire story